William Clyde Oldaker
CIK 1397571 · last filed 2019-07-03
William Clyde Oldaker is a corporate insider who has filed 26 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for CUR, was dated Jul 3, 2019. Across all open-market trades the lifetime net is −$8.6K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
WFBI price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 1100
WASHINGTON, DC 20006
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PALISADE BIO, INC. (CUR) Delisted | Director | 1,688 | — | — | $147.4K | 18 | 2019-07-03 |
| WashingtonFirst Bankshares, Inc. (WFBI) Delisted | Director | 180,855 | — | — | -$156.1K | 7 | 2017-05-08 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-07-03 | PALISADE BIO, INC. (CUR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-07-05 | PALISADE BIO, INC. (CUR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-01-03 | — | Disp (D) | −182,070 | $0 | |
| 2017-07-18 | PALISADE BIO, INC. (CUR) Delisted | Grant (A) | +18,622 | $0 | EDGAR |
| 2017-05-08 | WashingtonFirst Bankshares, Inc. (WFBI) Delisted | Exer (M) | +2,430 | $22.6K | EDGAR |
| 2017-05-05 | WashingtonFirst Bankshares, Inc. (WFBI) Delisted | Exer (M) | +3,487 | $45.9K | EDGAR |
| 2016-04-18 | WashingtonFirst Bankshares, Inc. (WFBI) Delisted | Exer (M) | +1,157 | $12.0K | EDGAR |
| 2015-11-20 | PALISADE BIO, INC. (CUR) Delisted | Exer (M) | +15,000 | $0 | EDGAR |
| 2015-07-06 | PALISADE BIO, INC. (CUR) Delisted | Grant (A) | +53,476 | $0 | EDGAR |
| 2015-06-02 | WashingtonFirst Bankshares, Inc. (WFBI) Delisted | Sell (S) | −3,392 | -$57.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.